Results 91 to 100 of about 18,494 (211)

Clostridioides difficile infection treatment guidelines adherence and comparison of treatment outcomes of the first, non-severe disease episode between oral metronidazole and vancomycin group: a single tertiary center retrospective study [PDF]

, 2019
Karlo Vidović, Nikolina Bogdanić, Mirjana Balen Topić   +2 more
openalex   +1 more source

The Role of Clostridioides difficile Within the One Health Framework: A Review

Microorganisms
Clostridioides difficile is the leading cause of antibiotic-associated diarrhea in hospitalized patients. In recent years, the incidence of C. difficile infection (CDI) has increased globally, with a notable rise in community-associated CDI (CA-CDI). The
Sotiris Alexiou, Anastasia Diakou, Melania Kachrimanidou   +2 more
doaj   +1 more source

Investigating the relationship between vancomycin-resistant Enterococcus control practices and the incidence of health care–associated Clostridioides difficile infections in Ontario [PDF]

, 2019
Rebecca Ling, Camille Achonu, Li Ye, Kevin Katz, Gary Garber, Jennie Johnstone   +5 more
openalex   +1 more source

The role of gut fungi in Clostridioides difficile infection

Biomedical Journal
Clostridioides difficile, the etiological agent of C. difficile infection (CDI), elicits a spectrum of diarrheal symptoms with varying severity and the potential to result in severe complications such as colonic perforation, pseudomembranous colitis, and toxic megacolon.
Lamei Wang, Yangchun Cao, Eddie Lou, Xuanyin Zhao, Xinhua Chen   +4 more
openaire   +3 more sources

Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides ( Clostridium ) difficile Infection [PDF]

, 2019
Fred C. Tenover, David H. Persing, Ferric C. Fang   +2 more
openalex   +1 more source

Clostridioides difficile infection: a changing treatment paradigm

Gastroenterology Review
Clostridioides difficile infection (CDI) poses a persistent challenge in healthcare, with substantial morbidity and mortality implications. This comprehensive review explores current CDI management, emphasising guidelines from IDSA, SHEA, and ESCMID.
Yousif Al Naser, Marriam AlGashami, Layth Aljashaami   +2 more
openaire   +3 more sources

Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013–2015 [PDF]

, 2019
Shannon Novosad, Yi Mu, Lisa G. Winston, Helen Johnston, Elizabeth Basiliere, Danyel Olson, Monica M. Farley, Andrew Revis, Lucy Wilson, Rebecca Perlmutter, Stacy Holzbauer, Tory Whitten, Erin C. Phipps, Ghinwa Dumyati, Zintars G. Beldavs, Valerie Ocampo, Corinne M. Davis, Marion Kainer, Dale N. Gerding, Alice Guh   +19 more
openalex   +1 more source

Mapping Epitopes of a Novel Peptidoglycan Cross-Linking Enzyme Cwp22 Recognized by Human Sera Obtained from Patients with Clostridioides difficile Infection and Cord Blood [PDF]

, 2019
Agnieszka Razim, Katarzyna Pacyga-Prus, Gayane Martirosian, Andrzej Szuba, Andrzej Gamian, Andrzej Myc, Sabina Górska   +6 more
openalex   +1 more source

Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection [PDF]

, 2020
Shakhinur Islam Mondal, Lorraine A. Draper, R. Paul Ross, Colin Hill   +3 more
openalex   +1 more source

Toxigenic profiles of clinical Clostridioides difficile in public and private healthcare settings in Gauteng, South Africa

International Journal of Infectious Diseases
Introduction: Clostridioides difficile infection (CDI) is a serious healthcare-associated infection causing life-threatening infectious diarrhea in hospitalized patients accounting for 20% to 30% of all diarrhoea cases in humans. Clostridioides difficile'
Dr Ben Prinsloo, Miss Hlambani Shirinda, Prof Anthony Smith, Prof Marthie Ehlers   +3 more
doaj   +1 more source